Utilizing enoxaparin in the management of STEMI.

Vasc Health Risk Manag · 2007 · PMC2291313 · PMID 18078020

Europe PMC

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

A favorable trend towards a complete ST-segment resolution at 180’ was observed in enoxaparin groups (pooled rate: 50% vs 43%).

also in 1,335 other papers

a clear trendno p-value reported

Also, the reocclusion rate at 5–7 days was comparable, although a clear trend favoring enoxaparin was evident (3% vs 9%).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.